Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in early rheumatoid arthritis
NCT00660647Phase 3Completed
- Sponsor
- Aarhus University
- Start
- Sep 2007
- Primary completion
- Dec 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of adalimumab in rheumatoid arthritis (RA), sponsored by Aarhus University. Started Sep 2007; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00660647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660647.